**16. Conclusion and summary**

SVT AF represents a costly public health problem due to its high prevalence and high morbidity attributed to the disease itself and inherent complications. It causes serious consequences through hemodynamic complications and thromboembolic problems such as stroke and acute arterial occlusion. POCUS/echocardiography is vital in patients with AF because it shows potential thromboembolism at its source and also reveals cardiac functions, valve and chamber problems. Safe and effective pharmacological or electrical cardioversion (PCV/ECV) are current treatments of choice in cases with acute AF while selected cases will be candidates for rate control strategy. BB, CCB, adenosine, amiodarone and propafenone are among the most commonly used agents in this regard. There is not a standard regimen to apply to every case, but specific agents need to be selected in regard to the patient and the situation.
